Annual Working Capital
$141.85 M
-$639.00 K-0.45%
30 September 2023
Summary:
Anavex Life Sciences annual working capital is currently $141.85 million, with the most recent change of -$639.00 thousand (-0.45%) on 30 September 2023. During the last 3 years, it has fallen by -$8.97 million (-5.94%). AVXL annual working capital is now -5.94% below its all-time high of $150.82 million, reached on 30 September 2021.AVXL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$129.78 M
-$5.18 M-3.84%
30 June 2024
Summary:
Anavex Life Sciences quarterly working capital is currently $129.78 million, with the most recent change of -$5.18 million (-3.84%) on 30 June 2024. Over the past year, it has dropped by -$12.07 million (-8.51%). AVXL quarterly working capital is now -17.41% below its all-time high of $157.15 million, reached on 30 June 2021.AVXL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVXL Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -8.5% |
| 3 y3 years | -5.9% | -13.9% |
| 5 y5 years | +599.1% | +539.6% |
AVXL Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -5.9% | at low | -14.7% | at low |
| 5 y | 5 years | -5.9% | +599.1% | -17.4% | +539.6% |
| alltime | all time | -5.9% | +3942.7% | -17.4% | +2145.1% |
Anavex Life Sciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $129.78 M(-3.8%) |
| Mar 2024 | - | $134.96 M(-0.5%) |
| Dec 2023 | - | $135.57 M(-4.4%) |
| Sept 2023 | $141.85 M(-0.4%) | $141.85 M(-3.3%) |
| June 2023 | - | $146.75 M(+1.1%) |
| Mar 2023 | - | $145.17 M(+7.4%) |
| Dec 2022 | - | $135.12 M(-5.2%) |
| Sept 2022 | $142.49 M(-5.5%) | $142.49 M(-5.5%) |
| June 2022 | - | $150.74 M(-1.0%) |
| Mar 2022 | - | $152.21 M(+4.0%) |
| Dec 2021 | - | $146.37 M(-3.0%) |
| Sept 2021 | $150.82 M(+453.7%) | $150.82 M(-4.0%) |
| June 2021 | - | $157.15 M(+107.3%) |
| Mar 2021 | - | $75.81 M(+63.7%) |
| Dec 2020 | - | $46.30 M(+70.0%) |
| Sept 2020 | $27.24 M(+34.2%) | $27.24 M(+10.4%) |
| June 2020 | - | $24.68 M(-0.4%) |
| Mar 2020 | - | $24.79 M(-4.5%) |
| Dec 2019 | - | $25.96 M(+27.9%) |
| Sept 2019 | $20.29 M(-8.5%) | $20.29 M(+16.1%) |
| June 2019 | - | $17.48 M(+23.3%) |
| Mar 2019 | - | $14.18 M(-17.7%) |
| Dec 2018 | - | $17.22 M(-22.3%) |
| Sept 2018 | $22.17 M(-8.4%) | $22.17 M(-5.8%) |
| June 2018 | - | $23.53 M(+5.1%) |
| Mar 2018 | - | $22.40 M(-12.1%) |
| Dec 2017 | - | $25.49 M(+5.3%) |
| Sept 2017 | $24.20 M(+286.9%) | $24.20 M(+3.4%) |
| June 2017 | - | $23.40 M(+9.2%) |
| Mar 2017 | - | $21.43 M(+12.1%) |
| Dec 2016 | - | $19.13 M(+205.7%) |
| Sept 2016 | $6.26 M(-51.2%) | $6.26 M(-18.4%) |
| June 2016 | - | $7.67 M(-20.8%) |
| Mar 2016 | - | $9.68 M(-15.7%) |
| Dec 2015 | - | $11.49 M(-10.3%) |
| Sept 2015 | $12.81 M | $12.81 M(+93.3%) |
| June 2015 | - | $6.63 M(+37.1%) |
| Mar 2015 | - | $4.83 M(-14.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | - | $5.63 M(-4.7%) |
| Sept 2014 | $5.91 M(-479.0%) | $5.91 M(-6.1%) |
| June 2014 | - | $6.29 M(-14.2%) |
| Mar 2014 | - | $7.34 M(-538.8%) |
| Dec 2013 | - | -$1.67 M(+7.2%) |
| Sept 2013 | -$1.56 M(-45.8%) | -$1.56 M(-56.1%) |
| June 2013 | - | -$3.55 M(+3.4%) |
| Mar 2013 | - | -$3.43 M(+3.2%) |
| Dec 2012 | - | -$3.33 M(+15.8%) |
| Sept 2012 | -$2.88 M(+151.2%) | -$2.88 M(+30.8%) |
| June 2012 | - | -$2.20 M(-25.0%) |
| Mar 2012 | - | -$2.93 M(+18.0%) |
| Dec 2011 | - | -$2.48 M(+116.9%) |
| Sept 2011 | -$1.14 M(-61.4%) | -$1.14 M(+17.3%) |
| June 2011 | - | -$976.30 K(-20.8%) |
| Mar 2011 | - | -$1.23 M(+1167.5%) |
| Dec 2010 | - | -$97.20 K(-96.7%) |
| Sept 2010 | -$2.96 M(-19.7%) | -$2.96 M(-53.3%) |
| June 2010 | - | -$6.35 M(+42.1%) |
| Mar 2010 | - | -$4.46 M(+2.4%) |
| Dec 2009 | - | -$4.36 M(+18.1%) |
| Sept 2009 | -$3.69 M(+61.0%) | -$3.69 M(+33.7%) |
| June 2009 | - | -$2.76 M(-13.5%) |
| Mar 2009 | - | -$3.19 M(+15.8%) |
| Dec 2008 | - | -$2.76 M(+20.3%) |
| Sept 2008 | -$2.29 M(+395.8%) | -$2.29 M(+28.8%) |
| June 2008 | - | -$1.78 M(+62.8%) |
| Mar 2008 | - | -$1.09 M(+148.5%) |
| Dec 2007 | - | -$440.10 K(-4.8%) |
| Sept 2007 | -$462.50 K(+2883.9%) | -$462.50 K(+2.4%) |
| June 2007 | - | -$451.80 K(+129.5%) |
| Mar 2007 | - | -$196.90 K(+608.3%) |
| Dec 2006 | - | -$27.80 K(+79.4%) |
| Sept 2006 | -$15.50 K(-40.4%) | -$15.50 K(+59.8%) |
| June 2006 | - | -$9700.00(-74.3%) |
| Mar 2006 | - | -$37.80 K(+14.2%) |
| Dec 2005 | - | -$33.10 K(+27.3%) |
| Sept 2005 | -$26.00 K(-201.6%) | -$26.00 K |
| Sept 2004 | $25.60 K | - |
FAQ
- What is Anavex Life Sciences annual working capital?
- What is the all time high annual working capital for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly working capital?
- What is the all time high quarterly working capital for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly working capital year-on-year change?
What is Anavex Life Sciences annual working capital?
The current annual working capital of AVXL is $141.85 M
What is the all time high annual working capital for Anavex Life Sciences?
Anavex Life Sciences all-time high annual working capital is $150.82 M
What is Anavex Life Sciences quarterly working capital?
The current quarterly working capital of AVXL is $129.78 M
What is the all time high quarterly working capital for Anavex Life Sciences?
Anavex Life Sciences all-time high quarterly working capital is $157.15 M
What is Anavex Life Sciences quarterly working capital year-on-year change?
Over the past year, AVXL quarterly working capital has changed by -$12.07 M (-8.51%)